- Research Article
- 10.1016/j.appet.2026.108485
Latent profile analyses of intuitive eating and motivation to regulate eating behaviors: Associations with diet quality, eating behaviors, and body image.
- Jun 01, 2026
- Appetite
- Thomas Sire + 3 more +3
Publications from 2021 to 2026
Showing 10 of 15,096 papers
Latent profile analyses of intuitive eating and motivation to regulate eating behaviors: Associations with diet quality, eating behaviors, and body image.
Criteria to Prioritize Clinical Practice Guideline Recommendations for Patient Decision Aid Development: Results from a Modified Delphi Consensus Study.
Impacts of phenolic compounds on RT-qPCR detection of hepatitis A virus in berries.
Berries are frequently implicated in outbreaks of foodborne illness due to viruses, particularly norovirus and hepatitis A virus. Compounds naturally present in berries can compromise the reliability of RT-qPCR methods, such as ISO 15216-1:2017, for detecting and quantifying viruses in foods. The aim of this study was to evaluate the inhibitory impact of seven phenolic compounds (ellagic acid, hydroxybenzoic acid, caffeic acid, coumaric acid, ferulic acid, quercetin, and cyanidine-3-glucoside) found naturally in raspberries as well as batch effects due to different concentrations of inhibitors (e.g., associated with ripeness) when using RT-qPCR to detect HAV in raspberries, blackberries, strawberries, blueberries, cranberries, and mixed berries. To assess the impact of dilution on RT-qPCR inhibition, samples were diluted at four levels (1/2, 1/5, 1/10, 1/100). Spiking the RT-qPCR reaction mixture with each phenolic compound at its natural concentration in raspberries showed that ellagic acid, hydroxybenzoic acid, caffeic acid and cyanidin-3-glucoside inhibited amplification, but only ellagic acid remained inhibitory in the ISO method. HAV recovery from frozen strawberries was undetectable (0%) without additional treatment but reached 39% with the OneStep PCR Inhibitor Removal Kit. For frozen blueberries, MobiSpin S-400 performed better, yielding about 52% recovery compared to 23% with OneStep. Sample dilution further enhanced HAV detection across most berry types.
Read moreAssessing the synergy between a mediterranean diet and physical activity on cardiometabolic risk: a 2x2 factorial randomized controlled study.
No randomized clinical trial (RCT) using a factorial design has yet tested the hypothesis that a healthy diet and regular physical activity (PA) have synergistic effects on cardiometabolic risk. to assess the synergy between a Mediterranean diet (MedDiet) and regular PA on postprandial triglyceridemia (TG) and other lipid risk factors. In this 2x2 factorial 16-week RCT, two hundred men and women with abdominal obesity and moderate hypertriglyceridemia (TG≥1.5mmol/L) were randomly assigned to one of four groups: 1-control, 2-MedDiet only, 3-PA only and 4-MedDiet+PA. MedDiet groups were counseled to adhere to a MedDiet and received key MedDiet foods. The PA intervention targeted 150min/week of moderate intensity exercise (65% of measured VO2peak). Controls were asked to maintain their usual dietary and PA habits. Postprandial serum TG was measured 4h after consumption of 35.1g fat/m2 of body surface area. The dropout rate among participants (mean [SD] age, 53.8 [10.6] years; 75.5% women) was 2.5%. There was a small synergistic effect of the MedDiet and PA on 4h postprandial TG (Pinteraction=0.025), the MedDiet+PA group exhibiting the lowest post-intervention 4h TG concentrations of all groups. There was also evidence of a small synergistic effect between treatments in reducing apolipoprotein B concentrations (Pinteraction=0.077) measured on the last day of intervention, which was no longer observed when measured 48h after the end of intervention. The combination of a MedDiet and regular PA may have small, short-lived synergistic effects on postprandial TG concentrations and other cardiometabolic risk factors.
Read moreSex differences in hemodynamics and remodeling patterns uncovered by automated Machine-Learning 3D echocardiography in aortic stenosis with preserved ejection fraction.
Women with aortic stenosis (AS) are underdiagnosed and undertreated compared to men and face a higher mortality risk despite similar symptoms and fewer comorbidities. Sex-specific differences in left ventricular (LV) remodeling may contribute to this disparity. We investigated whether a fully automated, machine-learning-based three-dimensional echocardiography (3DE) approach, the Dynamic Heart Model (DHM), improves the detection of these differences compared to conventional two-dimensional echocardiography (2DE). This study investigates sex-related differences in cardiac remodeling and hemodynamics in AS patients with a preserved ejection fraction (EF ≥ 50%), comparing results from 2D echocardiography (2DE) and 3D echocardiography (3DE) via the DHM. The study included 101 consecutive patients with AS (42% women) who were assessed with 2DE and DHM. Parameters such as LV volumes, mass (LVM), stroke volume (SV), and aortic valve area (AVA) were measured and indexed to body surface area (BSA). Sex-specific differences were analyzed, with a focus on identifying significant remodeling patterns. Women exhibited smaller LV end-diastolic volume (EDV) and end-systolic volume (ESV) by DHM compared to men (115 mL vs. 155 mL, p < 0.001; 51 mL vs. 66 mL, p < 0.001). Indexed EDV (EDVi) and ESV (ESVi) were also significantly lower in women (69 mL/m² vs. 84 mL/m², p < 0.001; 30 mL/m² vs. 34 mL/m², p = 0.002). LVM and indexed LV mass (LVMi) were significantly lower in women when measured by DHM (131g vs. 163g, p < 0.001; 75g/m² vs. 89g/m², p = 0.005), whereas 2DE did not reveal statistically significant differences. Women exhibited a more concentric LV geometry, as reflected by higher relative wall thickness than men (0.42 vs. 0.36; p = 0.04). Despite similar hemodynamic parameters, women had significantly smaller DHM-derived AVA (0.90cm² vs. 1.20cm², p < 0.001), correlating with reduced SV (64 mL vs. 90 mL, p < 0.001). This study highlights that significant sex-related differences in LV remodeling and AS severity are better captured by DHM than 2DE, emphasizing the importance of sex-specific considerations and accurate measurements in evaluating and managing AS.
Read moreInequities in Antiretroviral Therapy Costs for Pregnant Women and Pregnant People in Canada.
Antiretroviral therapy is critical for preventing perinatal HIV transmission during pregnancy; however, access is shaped by complex structural factors, including access to prenatal care, insurance status and provincial drug-coverage policies. Despite its importance, little is known about how out-of-pocket antiretroviral therapy costs during pregnancy differ within and across Canada. We performed a secondary analysis of Quebec data from the Canadian Perinatal HIV Surveillance Program collected between 2019 and 2023, which included 225 pregnant women and pregnant people living with HIV. Out-of-pocket antiretroviral therapy costs were estimated using insurance information, medication prices, and provincial drug formularies. Additionally, we modelled hypothetical case scenarios to examine how antiretroviral therapy costs during pregnancy differed based on income level and province of residence. In the Quebec cohort, out-of-pocket antiretroviral therapy costs during pregnancy varied substantially by insurance coverage. Individuals without insurance faced median costs in pregnancy nearly 10 times higher (CAD $9380) than those with public (CAD $934) or private insurance (CAD $1196). Those insured under the Interim Federal Health Program incurred no costs (CAD $0). Simulated scenarios across provinces and territories revealed further disparities, with some jurisdictions providing full public coverage while others required out-of-pocket payments up to CAD $4296. Out-of-pocket costs for antiretroviral therapy during pregnancy remain high and inequitably distributed in Canada, with uninsured individuals facing the greatest burden in Quebec. These findings highlight the need for policy reforms to ensure free and equitable access to antiretroviral therapy during pregnancy, regardless of insurance coverage.
Read moreNature-inspired ML for strength estimation and multi-objective optimization of cement-supplementary material-stabilized soft soils
Pharmacist-led interventions to optimize the pharmacotherapy of older adults under evaluation for or living with a neurocognitive disorder in the community: A quasi-experimental study.
Older adults living with neurocognitive disorders (NCD) face a higher risk of polypharmacy, exposure to potentially inappropriate medications and related adverse events. Pharmacists can help manage these issues and improve the appropriateness of pharmacotherapy. To evaluate the impact of pharmacists' interventions, as members of primary care interprofessional teams, on medication use and patient-reported outcome measures among older adults living with or under investigation for a neurocognitive disorder. The effect of a six-month follow-up by a primary care interprofessional team pharmacist on the number of medications, potentially inappropriate medications (PIMs) and anticholinergic burden for older adults living at home under evaluation for or living with a NCD was assessed through a controlled quasi-experimental study. Eligible older adults were 65 years or older and were enrolled between September 2021 and February 2025. The patient-reported outcomes were the evolution of participants' quality of life, treatment burden and satisfaction with care. The outcomes were evaluated using difference in differences (D-I-D) and their 95% confidence interval (95% CI). Pharmacist interventions significantly reduced the mean anticholinergic burden in the intervention arm (n=177) compared to the control arm (n=128) (D-I-D: -0.29; 95% CI: -0.56 - -0.11). A non-statistically significant trend toward a reduction was also observed for the mean number of PIMs (D-I-D: -0.11; [-0.22; 0.00]). The interventions also improved participants' satisfaction with care (6.97; [0.23; 13.72]). The mean number of medications used, as well as the burden of treatment and quality of life were stable after follow-up. Pharmacist-led interventions in interprofessional primary care settings contributed to the appropriateness of pharmacotherapy and satisfaction of older adults under evaluation for or living with a NCD after a six-month follow-up.
Read moreLinguistic vulnerabilities in mild cognitive impairment: Evidence from the DTLA-Tr screening battery.
Operationalising dementia prevention as a measurable NCD priority.
The 4th UN General Assembly declaration on non-communicable diseases (NCDs) and mental health, adopted on Dec 15, 2025, was notable for its explicit inclusion of dementia, bringing dementia prevention into focus as an international public policy priority.1 A central question therefore becomes how dementia prevention will be prioritised, resourced, and implemented and how it will be integrated into existing NCD policies and health-system strategies (appendix).
Read more